Shape the Future of Holistic Oncology Treatment
Company

Shape the Future of Holistic Oncology Treatment

Bringing a wealth of experience across the frontlines of oncology and tech, our leadership team is committed to building groundbreaking, integrative, and equitable healthcare solutions.

Discover the transformative world of Nipp—a digital health tech startup dedicated to providing concierge integrative care for cancer patients, survivors, and those at high risk of cancer. Our unique Three M model leverages biometric data from wearable devices to empower individuals and care teams, going beyond a digital-only approach. With a Personal Wellness Team featuring a wellness coach, nutritionist, and physical therapist/personal trainer—all specialized in oncology patient management—we deliver personalized, science-backed insights on movement, mindset, and meals. For enhanced support, Dee, our built-in AI Companion utilizes adaptive learning to offer guidance and refines Nipp’s recommendations based on individual responses.

movement
nutrition
meditation
growth
Team

Meet Our Team

Monique Gary

Monique Gary, DO

Breast Surgeon Oncologist, Founder

 

Kristie Powell

Kristie Powell

Engineering

 

Thandi Montgomery

Thandi Montgomery

Operations

 

Mark Castillo

Mark Castillo

Customer Success

 

Sara Horton

Sara Horton, MD

Advisor

Oncologist and Executive Director of Access and Diversity

Philip Mandato, Jr. DO

Advisor

Anesthesiologist and Lifestyle Medicine Expert

Joy Jang

Joy Jang, PT, PhD, CLT

Advisor

Orthopedic
Physical Therapist

Lincoln Bryden

Lincoln Bryden

Advisor

Best selling author, International fitness consultant, Health and wellness expert

Maria Nero

Maria Nero

Advisor

Health Data Analyst

Ideation

Ideation

Conceived the innovative idea for Nipp and developed a robust business plan.

2022
Development

Development

Dedicated efforts to software development, bringing the beta version of Nipp to life.

2023
BETA Launch

BETA Launch

ocused on patient recruitment for a pilot phase, aiming to validate and refine Nipp's effectiveness in personalized patient care.

2024